These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 327250)

  • 1. The action of antitumor agents: a double-edged sword?
    Sieber SM
    Med Pediatr Oncol; 1977; 3(2):123-31. PubMed ID: 327250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recently recognized complications of cancer chemotherapy.
    Arseneau JC; Canellos GP; DeVita VT; Sherins RJ
    Ann N Y Acad Sci; 1974; 230():481-8. PubMed ID: 4595953
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer and secondary leukemia.
    Rosner F
    Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Petru E; Schmähl D
    Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
    Schein PS; Winokur SH
    Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three cases of secondary leukemia. Clinicopathologic findings.
    Nemoto K; Honma K; Ohnishi Y; Abe M; Abe A
    Acta Pathol Jpn; 1987 May; 37(5):817-30. PubMed ID: 3477055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
    Ali NO; Janes WO
    Cancer; 1979 Apr; 43(4):1211-5. PubMed ID: 445324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukemias and Burkitt's lymphoma. Present status of therapy.
    Zubrod CG
    Cancer; 1968 Apr; 21(4):553-7. PubMed ID: 4296158
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
    Cridland MD
    Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal infection with Aeromonas hydrophila in a patient with acute myelogenous leukemia.
    Dean HM; Post RM
    Ann Intern Med; 1967 Jun; 66(6):1177-9. PubMed ID: 5230032
    [No Abstract]   [Full Text] [Related]  

  • 16. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
    Aisenberg AC
    Am J Med; 1983 Sep; 75(3):449-54. PubMed ID: 6688502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
    Bartolucci AA; Liu C; Durant JR; Gams RA
    Cancer; 1983 Dec; 52(12):2209-13. PubMed ID: 6580060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Cancer chemotherapeutic agents and carcinogenesis.
    Sieber SM
    Cancer Chemother Rep; 1975; 59(5):915-8. PubMed ID: 1060510
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.